P-21 (10 mg/10 ml) Nasal Spray (nootropic peptide)

Description

P21 Spray is a nasal peptide spray marketed as a cognitive support product for attention, memory, concentration, and stress resilience. It is described as having neuroplasticity and neuroprotection benefits, and its spray format is designed for easy and quick application. It is used in protocols for enhancing focus, maintaining memory, adapting to stress, and stabilizing cognitive function during shifts in workload.

Reasons to choose P21 Spray

• Fast action and easy to use
• Gentle daily support without energy surges
• Suitable for work, study and stressful workloads
• Combines well with Oxytocin, Semax, PE-22-28
• Ideal for regular cognitive protocols, P21 Spray is the choice of those who want to maintain mental clarity, work at a high pace, and maintain emotional stability.
• The format is suitable for stress adaptation and cognitive prevention programs in a busy lifestyle.

Main possible effects of P-21 (with scientific terminology)

Effect Scientific justification

What aspects of health can P-21 with Adamantane support:

In scientific research,  P21 spray  is being studied as a compound that influences the recovery and adaptation processes of the central nervous system.  P-21 spray with Adamantane  is being studied for its cognitive support and neuroprotection.

• Support of neuronal survival in neurodegenerative processes
• Promoting restoration of central nervous system functions after injury
• Support of cognitive processes (memory, learning, concentration)
• Reduction of neuroinflammatory reactions

Comparison with similar peptides and telomerase activators

Unlike telomerase activators, which target cellular aging,  P-21  primarily targets neurotrophic mechanisms. Compared to other neuropeptides, P-21 with Adamantane spray is characterized by increased stability and enhanced penetration due to its modification with adamantane.

Research and expert publications (scientific sources)

P-21 studies were conducted on cellular and animal models of neurodegenerative diseases and CNS injuries. The experiments assessed neuronal survival, neuroinflammation, neurotrophic factor activity, and cognitive function.

The results showed increased neurogenesis in the hippocampus, increased BDNF expression, and reduced inflammatory markers. Separate studies demonstrate the potential role of P-21 in models of Alzheimer’s disease, stroke, and traumatic brain injury. Clinical efficacy and safety are ongoing.

Side effects and important warnings

Data on P-21’s side effects are limited to experimental studies. Individual reactions related to its effects on the central nervous system and neuroinflammatory processes are possible.

• headache or feeling of discomfort;
• weakness, fatigue;
• mild dizziness;
• sleep disturbances or increased excitability;
• rarely – short-term changes in blood pressure or heart rate;
• uncommon gastrointestinal reactions including nausea.

The use of P-21 should be carried out exclusively under the supervision of a physician, taking into account the individual characteristics of the body and possible risks.

1 bottle contains 100 doses of 100 mcg.

Apply the spray in the first half of the day, 1 spray in each nostril.

P-21 with Adamantane spray  contains a synthetic peptide with a precisely defined structure and a high degree of purification, which ensures the reproducibility of its biological properties.

• Amino acid sequence:  Ac-DGGLAG-NH2
• Molecular formula:  C27H42N6O8
• Molecular weight:  578.3 ±1 Da
• Modification:  adamantane (improved lipophilicity and stability)
• Purity:  99.4%